Radionuclide therapy revisited
CA Hoefnagel - European journal of nuclear medicine, 1991 - Springer
Apart from its use in endocrinology and rheumatology, therapeutic nuclear medicine is
developing rapidly as an additional treatment modality in oncology. Many different specific …
developing rapidly as an additional treatment modality in oncology. Many different specific …
[BOOK][B] The pharmaceutical codex: principles and practice of pharmaceutics.
W Lund - 1994 - cabidigitallibrary.org
The objective of this augmented and redesigned Codex is to provide a reference source on
those aspects of pharmaceutical science and technology that are applied in the …
those aspects of pharmaceutical science and technology that are applied in the …
[BOOK][B] Technetium: chemistry and radiopharmaceutical applications
K Schwochau - 2008 - books.google.com
Dieses einzigartige Handbuch gibt eine umfassende Übersicht über den aktuellen Stand
der Technetium-Chemie und die Anwendung von Technetium in der Radiopharmazie. Klar …
der Technetium-Chemie und die Anwendung von Technetium in der Radiopharmazie. Klar …
Towards molecular imaging and treatment of disease with radionuclides: the role of inorganic chemistry
P Blower - Dalton Transactions, 2006 - pubs.rsc.org
Molecular imaging and radiotherapy using radionuclides is a rapidly expanding field of
medicine and medical research. This article highlights the development of the role of …
medicine and medical research. This article highlights the development of the role of …
[BOOK][B] Werner & Ingbar's the thyroid: a fundamental and clinical text
SC Werner, SH Ingbar, LE Braverman, RD Utiger - 2005 - books.google.com
Completely updated for its Ninth Edition, this classic text provides comprehensive coverage
of every aspect of thyroid anatomy, development, biochemistry, physiology …
of every aspect of thyroid anatomy, development, biochemistry, physiology …
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study
M Diehl, JH Risse, K Brandt-Mainz, M Dietlein… - European journal of …, 2001 - Springer
The aim of this study was to evaluate the clinical use of fluorine-18 fluorodeoxyglucose
positron emission tomography (FDG-PET) in medullary thyroid cancer (MTC) on the basis of …
positron emission tomography (FDG-PET) in medullary thyroid cancer (MTC) on the basis of …
Redifferentiation therapy-induced radioiodine uptake in thyroid cancer
F Grunwald, C Menzel, H Bender… - The Journal of Nuclear …, 1998 - search.proquest.com
Due to a dedifferentiation of tumor cells, some thyroid carcinomas lose their capability for
radioiodine (RI) concentration. This phenomenon is associated with a worse prognosis and …
radioiodine (RI) concentration. This phenomenon is associated with a worse prognosis and …
[PDF][PDF] Pentavalent [99mTc] DMSA,[131I] MIBG, and [99mTc] MDP-an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid
SEM Clarke, CR Lazarus, P Wraight… - Journal of Nuclear …, 1988 - Soc Nuclear Med
MATERIALS AND METHODS Nine patients were studied with a histologie diagnosis of MCT
and persistently elevated calcitonin levels. Eight of these patients had …
and persistently elevated calcitonin levels. Eight of these patients had …
[BOOK][B] Metal compounds in cancer therapy
SP Fricker - 2012 - books.google.com
The discovery of the antitumour activity of cisplatin in 1965 and its subsequent introduction
into clinical trials in 1971 was the catalyst for a major international research effort …
into clinical trials in 1971 was the catalyst for a major international research effort …
Receptor PET/CT imaging of neuroendocrine tumors
Receptor PET/CT Imaging of Neuroendocrine Tumors | SpringerLink Skip to main content
Advertisement SpringerLink Account Menu Find a journal Publish with us Track your research …
Advertisement SpringerLink Account Menu Find a journal Publish with us Track your research …